Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 8/20 | 0.54 |
| ▸ | HTR1A | P08908 | 7/20 | 0.54 |
| ▸ | HTR2C | P28335 | 4/20 | 0.52 |
| ▸ | HTR2B | P41595 | 4/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | SCD | O00767 | 2/20 | 0.45 |
| ▸ | BCL9 | O00512 | 1/20 | 0.43 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
| ▸ | CHUK | O15111 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3880092 | 1.00 | SLC6A2 (0.54) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| Hydrochloric Acid SCHEMBL2949591 | 0.98 | SLC6A2 (0.52) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| SCHEMBL473045 | 0.91 | HTR1A (0.51) | SLC6A2HTR1AHTR2CHTR2BSLC6A3 | |
| Hydrochloric Acid SCHEMBL3140594 | 0.89 | HTR1A (0.50) | SLC6A2HTR1AHTR2CHTR2BSLC6A3 | |
| SCHEMBL13234945 | 0.88 | HTR2C (0.55) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| SCHEMBL3864751 | 0.87 | SLC6A4 (0.51) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| Hydrochloric Acid SCHEMBL2943264 | 0.87 | HTR2C (0.54) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| Hydrochloric Acid SCHEMBL2160831 | 0.86 | SLC6A4 (0.50) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| SCHEMBL23161332 | 0.84 | SLC6A2 (0.64) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 | |
| Hydrochloric Acid SCHEMBL72907 | 0.83 | SLC6A2 (0.62) | SLC6A2HTR1AHTR2CHTR2BSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7754745-B2 | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-07-13 | — | — | US | disclosed |
| US-7754745-B2 | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-07-13 | — | — | US | disclosed |
| US-7754745-B2 | Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase | MERCK FROSST CANADA LTD. (CA) | 2010-07-13 | — | — | US | disclosed |
| US-20090093527-A1 | Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. (CA) | 2009-04-09 | — | — | US | disclosed |
| US-20090093527-A1 | Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. (CA) | 2009-04-09 | — | — | US | disclosed |
| US-20090093527-A1 | Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | MERCK FROSST CANADA LTD. (CA) | 2009-04-09 | — | — | US | disclosed |
| EP-2032570-A1 | AZACYCLOPENTANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | Merck Frosst Canada Ltd. (CA) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007143824-A1 | AZACYCLOPENTANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. (CA) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007143824-A1 | AZACYCLOPENTANE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. (CA) | 2007-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093527-A1 | Azacyclopentane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase | SCD, SCD5, SREBF1 | SLC6A2 4386/4885HTR1A 2725/4885HTR2C 4631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.